BOI Bank Irel13.375

RNS Number:2302M
Biotrace International PLC
12 May 2005


For Immediate Release:                                              12 May 2005





                           BIOTRACE INTERNATIONAL PLC

                   ("Biotrace", the "Group" or the "Company")



                                 AGM Statement





Biotrace International Plc, a leading manufacturer and supplier of industrial
microbiology and life science products, held its Annual General Meeting today at
11am at the Company's Head Office in Bridgend, Wales.



Following the meeting the Company's Chairman, Mr Terry Clements, issued this
statement:



"As reported in our preliminary statement in March this year, management is
making solid progress in improving the financial performance of the Group.
Operating margins have remained robust, despite an increasingly competitive
trading environment. The recent introduction of regional management and
improvements in product manufacturing are placing the Company in a stronger
competitive position to address the global market for industrial microbiology
products.  Biotrace remains strongly cash generative and is well placed to
further add value to our customers and shareholders.



"We are pleased to announce that all resolutions proposed were duly passed,
including a proposal to pay a final dividend to shareholders of 1.15p per share.
  This, together with the interim dividend of 0.25p, brings the total dividend
for the year to 1.40p, an increase of 22% on 2003.



"We also announce today that Dr. Eurof Evans is retiring as a non-executive
director of the Company.  Eurof, 74, has been a non-executive director since
1996, prior to which he was Company Chairman and helped steer Biotrace through
its successful flotation in November 1993."



Ian Johnson, Chief Executive of Biotrace commented:



"We are grateful to Eurof for the tremendous contribution he has made to
Biotrace over the last 16 years. The Group has developed significantly during
this time and we thank Eurof for his dedication, enthusiasm and expertise.  I
speak for the board when I wish Eurof our very best for the future."



                                    - ENDS -



For further information, please contact:
Biotrace International
Ian Johnson, Chief Executive Officer                   Tel : +44 (0)1656 641 400
Peter Morgan, Finance Director

Buchanan Communications
Tim Andersen / James Strong                             Tel: +44 (0)20 7466 5000







Notes to editors:

Biotrace International Plc is a leading manufacturer and supplier of
microbiology instrumentation and test reagents to industrial, healthcare and
defence markets.  Biotrace is the acknowledged leader in rapid hygiene testing
and the continuous real-time detection of airborne biological weapons.



Most of the world's leading food manufacturers and catering companies rely on
Biotrace as an essential part of their quality procedures. Industrial customers
also include many of the world's largest water treatment chemical
multi-nationals.  Biotrace also supplies highly specialised workstations to
hospitals, public health laboratories and medical research institutes for the
examination of micro-organisms and diseases. Since 1991 the Company has
manufactured and equipment and reagents for the detection of biological weapons,
which it supplies to the UK MoD, other foreign governments and large defence
contractors,.



Formed in 1988 and floated on the London Stock Exchange in 1993, Biotrace
intends to continue to broaden its business base through organic growth and
acquisition of products and technologies to become a 'one stop shop' for its
large and growing international customer base.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGMBDGDULGBGGUD

Bank Irel13.375 (LSE:BOI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024

Bank Irel13.375 (LSE:BOI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024